康泰生物 (300601.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(康泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 733,895,892.28982,185,584.95748,383,301.39592,337,676.63737,220,176.66956,418,402.64871,425,498.86
 营业收入(元) 733,895,892.28982,185,584.95748,383,301.39592,337,676.63737,220,176.66956,418,402.64871,425,498.86
二、营业总成本(元) 551,578,003.91678,254,579.73502,644,829.28636,396,272.74669,230,185.31750,664,619.73561,389,213.81
 营业成本(元) 114,429,496.41123,946,920.90105,437,431.28167,089,133.2189,479,788.08121,025,530.11122,352,996.55
 研发费用(元) 113,694,814.91160,338,827.4484,466,623.59220,973,745.78240,814,770.19244,465,423.8895,602,775.74
 营业税金及附加(元) 3,599,838.037,420,512.814,170,169.454,931,844.774,270,597.776,880,045.874,409,467.96
 销售费用(元) 249,081,018.05337,232,568.87259,204,013.18199,695,845.47279,625,672.42318,304,337.25288,734,487.19
 管理费用(元) 71,298,478.0448,397,424.2551,650,868.4843,264,509.4858,340,443.5570,944,321.2857,629,097.33
 财务费用(元) -525,641.53918,325.46-2,284,276.70441,194.03-3,301,086.70-10,955,038.66-7,339,610.96
  其中:利息费用(元) 28,372,994.9428,030,335.9127,481,440.9628,039,888.3727,176,698.2627,518,065.0926,237,523.93
  其中:利息收入(元) 29,109,481.2227,121,014.2929,811,258.7027,326,231.0531,174,801.0638,728,391.3535,395,405.66
 资产减值损失(元) -862,092.17-34,475,691.69-8,695,078.99-412,200,837.50-35,577,450.47-438,513,667.57-10,201,058.78
 信用减值损失(元) -1,300,417.72-23,798,592.86-13,726,239.46-14,083,991.26-3,670,844.02-14,213,533.40-7,515,728.59
三、其他经营收益
 加:公允价值变动收益(元) 96,580.19--2,817,504.3922,300.00243,435.0093,628.84
 加:投资收益(元) -231,567.661,466,592.11849,695.53---
 资产处置收益(元) -1,374,555.64---25,812.12-1,826.06--
 其他收益(元) 23,515,452.2275,221,737.5919,563,457.11-3,457,697.1735,490,381.987,615,634.7434,787,977.53
四、营业利润(元) 202,392,855.25322,009,215.04244,347,202.88-470,159,734.2464,346,906.62-238,959,276.19327,201,104.05
 加:营业外收入(元) 160,754.49186,041.30192,004.30532,215.821,143,393.684,713,100.61224,353.27
 减:营业外支出(元) 1,311,610.00252,813.742,721,147.9211,892,260.036,808,691.123,162,529.795,425,045.07
五、利润总额(元) 201,241,999.74321,942,442.60241,818,059.26-481,519,778.4558,681,609.18-237,408,705.37322,000,412.25
 减:所得税费用(元) 14,622,652.6116,973,745.5036,355,239.01-145,664,822.73-23,962,663.10-84,323,209.9548,412,092.68
六、净利润(元) 186,619,347.13304,968,697.10205,462,820.25-335,854,955.7282,644,272.28-153,085,495.42273,588,319.57
(一)按经营持续性分类
  持续经营净利润(元) 186,619,347.13304,968,697.10205,462,820.25-335,854,955.7282,644,272.28-153,085,495.42273,588,319.57
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 186,619,347.13304,968,697.10205,462,820.25-335,854,955.7282,644,272.28-153,085,495.42273,588,319.57
 扣除非经常性损益后的净利润(元) 168,718,812.41240,125,960.96189,737,144.39-326,355,054.0657,200,910.49-161,954,648.11248,359,636.67
七、每股收益
 一、基本每股收益(元) 0.170.280.18-0.360.07-0.220.40
 二、稀释每股收益(元) 0.170.280.18-0.360.07-0.220.40
九、综合收益总额(元) 186,619,347.13304,968,697.10205,462,820.25-335,854,955.7282,644,272.28-153,085,495.42273,588,319.57
 归属于母公司所有者的综合收益总额(元) 186,619,347.13304,968,697.10205,462,820.25-335,854,955.7282,644,272.28-153,085,495.42273,588,319.57
公告日期 2023-10-272023-08-262023-04-242023-04-242022-10-282022-08-192022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院